福达合金 2025 年第一次临时股东大会 福达合金材料股份有限公司 会议资料 福达合金 2025 年第一次临时股东大会 目 录 福达合金 2025 年第一次临时股东大会 一、 会议时间 票时间为股东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30， 临时股东大会开始。 福达合金 2025 年第一次临时股东大会 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证 大会的顺利进行，根据相关法律法规、《公司章程》和《股东大会议事规则》等 规定，特制定本须知。 一、 公司根据《公司法》《证券法》《公司章程》和《公司股东大会议事规则》 等相关规定，认真做好召开股东大会的各项工作。 二、 大会设会务组，具体负责大会有关程序及服务等事宜。 福达合金 2025 年第一次临时股东大会 议案一：关于调整公司治理架构并废止《监事会议事规则》 的议案 各位股东及股东代表: 根据 2024 年 7 月 1 日起实施的《中华人民共和国公司法》 （2023 年修订）、 请各位股东审议。 《上市公司章程指引》 （2025 年修订）等相关法律法规的规定及中国证券监督管 理委员会于 2024 年 12 月 ...

一、会议召开和出席情况 （一）会议召开情况 本次会议的召集、召开和议案审议程序等符合有关法律、行政法规、部门规章 等规范性文件，符合《公司法》《公司章程》的有关规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 证券代码：833230 证券简称：欧康医药 公告编号：2025-097 成都欧康医药股份有限公司 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 《上市公司章程指引》以及《北京证券交易所股票 上市规则》等相关法律法规、规范性文件的规定，结合公司实际情况，公司拟不 再设置监事会，监事会的职权由董事会审计委员会行使，同时拟对《公司章程》 二、议案审议情况 的相关条款进行修订。在公司股东会审核通过取消监事会及修订《公司章程》事 项前，公司监事尚需履行原监事职权。 （一）审议通过《关于取消监事会并修订 <公司章程> 的议案》 根据《公司法》 《证券法》 根据《公司法》 《证券法》 具体内容详见公司于 2025 年 9 月 1 日在北京证券交易所信息披露平台 （www.bse ...

Group 1 - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 12, 2025, at 14:30 [3][40] - The meeting will be conducted both in-person and via the Shanghai Stock Exchange's online voting system [3][5] - Shareholders can vote through the trading system or the internet voting platform on the day of the meeting [6][12] Group 2 - The company has proposed several resolutions for the upcoming shareholders' meeting, including amendments to the Articles of Association and adjustments to the corporate governance structure [23][24] - The board of directors and the supervisory board have approved the proposals, which will be submitted for shareholder approval [21][44] - The company will provide a reminder service for shareholders to participate in the meeting and vote [6][14] Group 3 - The registration for attending the meeting will take place on September 9, 2025, at the company's headquarters [11] - Shareholders must present valid identification and relevant documents to register for the meeting [11][12] - The company will also hold a half-year performance briefing on September 4, 2025, to discuss its operational performance and strategic direction [48][49]

Group 1 - The company has adjusted its governance structure by abolishing the Supervisory Committee and transferring its powers to the Audit Committee of the Board of Directors [2][3] - The decision to abolish the Supervisory Committee is in accordance with the revised Company Law of the People's Republic of China effective from July 1, 2024, and relevant regulations [2][3] - The company assures that the cancellation of the Supervisory Committee will not adversely affect its governance or operational activities [2] Group 2 - The company plans to revise its Articles of Association to reflect the changes in governance structure and the abolition of the Supervisory Committee [3] - The proposed amendments to the Articles of Association will be submitted for approval at the shareholders' meeting [2][3]

证券代码：002823 证券简称：凯中精密 公告编号：2025-028 深圳市凯中精密技术股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏。 深圳市凯中精密技术股份有限公司（以下简称"公司"）于2025年8月13日召 开了第五届董事会第八次会议，会议审议通过了《关于修订 <公司章程> 的议案》， 根据《中华人民共和国公司法》《上市公司章程指引》等法律法规及规范性文件 的规定，结合公司的实际情况，公司拟对《深圳市凯中精密技术股份有限公司章 程》 （以下简称"《公司章程》"）进行修订并拟调整公司治理架构，监事会的职权 由董事会审计委员会行使，《监事会议事规则》相应废止。 此议案尚需提交股东会审议，并提请股东会授权董事会全权办理与本次章程 修改、工商备案等相关事宜。《公司章程》最终修改情况以工商行政管理部门核 准结果为准。股东会审议通过《关于修订 <公司章程> 的议案》前，第五届监事会 及监事仍将严格按照法律法规的要求，勤勉尽责履行监督职能，维护公司和全体 股东利益。 《公司章程》条款修订前后内容对照如下： 修订前 修订后 第一条 为维护公司、股东和债 ...

Core Viewpoint - The company has revised its governance structure by abolishing the supervisory board and establishing employee representative directors, which was approved in the first extraordinary shareholders' meeting of 2025 held on July 18, 2025 [1][3]. Group 1: Governance Changes - The company has canceled the supervisory board and set up employee representative directors as part of its governance structure adjustment [1]. - The board of directors will consist of nine members, including one employee representative director, elected by the employee representative assembly [3]. - The company has appointed Ma Yanjun as the employee representative director, whose term aligns with the second board of directors [3]. Group 2: Resignation of Directors - Non-independent director Zhou Fang has resigned from his position but will continue as the head of the sales management department [2]. - Vice General Manager Guo Yujie has also resigned from his role but will remain a director and Chief Product and User Officer [2]. - Both resignations will not affect the normal operation of the company, and their reports are effective upon delivery to the board [2][3]. Group 3: Compliance and Shareholding - Zhou Fang and Guo Yujie each hold 5,400 shares in the company and will manage their holdings according to relevant regulations [2][3]. - Both individuals have fulfilled their public commitments and will ensure proper work handover [2][3]. Group 4: Background of New Director - Ma Yanjun, the newly elected employee representative director, is a female with a master's degree and has no shares in the company [6]. - She has no connections with the company's actual controllers or other directors and has not faced any penalties from regulatory authorities [6].